SCHEMBL23273229

SCHEMBL23273229

CSCCC(NC(=O)C(CCCCN)NC(=O)C(N)C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(N)=O)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NC(C(=O)NCC(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(C)C)C(=O)O)C(C)C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NMBR P28336 2/20 0.69
▸ GRPR P30550 2/20 0.69
▸ GLP1R P43220 4/20 0.67
▸ GCGR P47871 3/20 0.67
▸ C5AR1 P21730 1/20 0.66
▸ NPY1R P25929 1/20 0.64
▸ NPY2R P49146 1/20 0.64
▸ NPY4R P50391 1/20 0.64
▸ NPY5R Q15761 1/20 0.64
▸ CTSL P07711 3/20 0.64
▸ CTSS P25774 3/20 0.64
▸ CTSK P43235 3/20 0.64
▸ CTSH P09668 1/20 0.64
▸ CALCR P30988 3/20 0.62
▸ MC4R P32245 1/20 0.59
▸ MC5R P33032 1/20 0.59
▸ MC3R P41968 1/20 0.59
▸ MC1R Q01726 1/20 0.59
▸ CXCR4 P61073 1/20 0.59
▸ KEAP1 Q14145 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20764721 0.94 GRPR (0.70) NMBRGRPRGLP1RGCGRC5AR1
SCHEMBL31083828 0.93 GLP1R (0.70) NMBRGRPRGLP1RGCGRC5AR1
SCHEMBL29366899 0.93 GLP1R (0.70) NMBRGRPRGLP1RGCGRC5AR1
SCHEMBL30658250 0.92 GLP1R (0.69) NMBRGRPRGLP1RGCGRNPY1R
SCHEMBL30932062 0.92 GLP1R (0.74) NMBRGRPRGLP1RGCGRC5AR1
SCHEMBL29599666 0.92 GLP1R (0.70) NMBRGRPRGLP1RGCGRC5AR1
SCHEMBL31182680 0.91 GLP1R (0.74) NMBRGRPRGLP1RGCGRC5AR1
SCHEMBL30578647 0.91 GLP1R (0.73) NMBRGRPRGLP1RGCGRC5AR1
SCHEMBL29587969 0.91 GLP1R (0.73) NMBRGRPRGLP1RGCGRC5AR1
SCHEMBL30082666 0.90 GLP1R (0.73) NMBRGRPRGLP1RGCGRC5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911451-B2 Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers ImmuLogix Ltd (US) 2024-02-27 — — US disclosed
US-20210121546-A1 COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS ImmuLogix Ltd (US) 2021-04-29 — — US disclosed
Send feedback